Navigation Links
Cylex(TM) Awarded New CPT Code For Its ImmuKnow(R) Assay
Date:1/12/2010

COLUMBIA, Md., Jan. 12 /PRNewswire/ -- Cylex Incorporated® announced today that the American Medical Association (AMA) CPT Editorial Panel approved the creation of new CPT coding based on the uniqueness, clinical value and widespread use of ImmuKnow, and the fact that existing CPT codes insufficiently captured all steps and costs of testing.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100112/NE34738LOGO )

In an effort to keep customers informed of these changes, the following new information is now available:

  • ImmuKnow is mapped to CPT Code: 86352, "Cellular function assay involving stimulation (e.g., mitogen or antigen) and detection of a biomarker (e.g., ATP)"

"We are very pleased by the decision of the AMA to recognize the value of ImmuKnow as a biomarker that provides valuable insight for individualized patient management by establishing a unique CPT code," said President, CEO and Chairman Brad L. Stewart. "We look forward to assisting clinicians with continuing to expand the implementation of ImmuKnow as standard of care in more effectively managing their patients' immunosuppression."

ImmuKnow is a biomarker of immune function that complements immunomodulatory therapy and helps physicians and other healthcare professionals more effectively manage immunosuppression in posttransplant patients, thereby reducing the risks of infection and rejection by:

  • Providing a global marker of immune function and response to immunosuppression at the cellular level
  • Detecting changes in CD4 cell ATP production
  • Helping to define a range of stable immune function for each patient
  • Providing critical, actionable information on an ongoing, individual basis when used longitudinally (in combination with other routine monitoring tests)

ImmuKnow is the FDA-cleared assay that tracks changes in global immune function over time.

*CPT = Current Procedural Terminology

About ImmuKnow

ImmuKnow is a noninvasive biomarker of immune function that assesses cellular immune status by detecting cell-mediated immunity (CMI) in adult immunosuppressed patients. It measures the concentration of adenosine triphosphate (ATP) released from CD4 cells following cell stimulation. The ImmuKnow assay is a qualitative assay and does not directly quantify the level of immunosuppression. Results of the ImmuKnow assay should be used in conjunction with clinical presentation, medical history, and other clinical indicators when assessing the immune status of any individual patient. ImmuKnow is increasingly being adopted at organ transplant centers throughout the United States and abroad.

About Cylex, Inc.

Cylex is the commercial global life sciences company leading the development and manufacture of in vitro diagnostic assays that measure cellular immune function. The Company's unique technology detects cell-mediated immunity, which presents an exciting opportunity for development of additional assays for diseases, and companion diagnostics for treatments, that affect the immune system. ImmuKnow, its first commercial product, is an FDA-cleared, noninvasive biomarker of immune function which is utilized by clinicians to more effectively manage and optimize immunosuppression in organ transplant patients. Cylex is a Technology Fast 500™ award winner for 2009, Deloitte LLP's ranking of 500 of the fastest growing technology companies in North America. The Company is based in Columbia, MD USA.

SOURCE Cylex, Inc.

RELATED LINKS
http://www.cylex.net

'/>"/>

SOURCE Cylex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. LSUHSC awarded multi-million dollar grant to reduce pneumonia
2. K-State plant pathology professor awarded international professorship for Latin America
3. Penn, Georgia collaboration awarded $14.6 million to expand pathogen database
4. Air Force Center of Excellence awarded in nanostructures and improved cognition
5. Stanford researchers awarded $6.27 million to study energy efficiency and human behavior
6. University of Miami facility awarded prestigious LEED Green Building Certification
7. Professor Suzanne Cory awarded 2009 Pearl Meister Greengard Prize
8. UNC awarded $6.2 million renewal grant by NIH Rare Diseases Research Network
9. VBI awarded $27 million from NIH to support infectious disease research
10. UNC awarded Cancer Genome Atlas grant
11. 2 neuroscientists from Cold Spring Harbor Laboratory awarded transformative NIH grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
(Date:3/18/2016)... -- --> --> Competitive ... Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance & Detection Systems ... security market and the continuing migration crisis in the ... has led visiongain to publish this unique report, which ... defence & security companies in the border security market ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... ... April 27, 2016 , ... Cambridge Semantics, the ... technology, today announced that it has been named to The Silicon Review’s “20 Fastest ... and other markets, Cambridge Semantics serves the needs of end users facing some of ...
(Date:4/27/2016)... ... ... Pittcon Organizing Committee is pleased to announce that Charles “Chuck” Gardner was named president ... Since then, he has served in a number of key leadership positions including secretary ... and exposition committees. In his professional career, Dr. Gardner is the director of product ...
(Date:4/27/2016)... , April 27, 2016 ... (CSE: NSK) (OTCPink: NSKQB) ( Frankfurt ... an ihre Pressemitteilung vom 13. August 2015 die ... ihre Finanzen um zusätzliche 200.000.000 Einheiten auf 400.000.000 ... Dollar zu bringen. Davon wurden 157.900.000 Einheiten mit ...
(Date:4/27/2016)... ... April 27, 2016 , ... ... pleased to announce the appointment of John Tilton as Chief Commercial Officer.  Mr. ... and one of the founding commercial leaders responsible for the commercialization of multiple ...
Breaking Biology Technology: